Thoracic Surgeons' Insights: Improving Thoracic Surgery Outcomes During the Coronavirus Disease 2019 Pandemic

Overview

Journal Ann Thorac Surg

Publisher Elsevier

Specialties General Surgery
Pulmonary Medicine

Date 2020 Jun 9

PMID 32507411

Citations 1

Authors

Ke-Neng Chen

Shugeng Gao

Lunxu Liu

Jianxing He

Ge-Ning Jiang

Jie He

Affiliations

Soon will be listed here.

Citing Articles

Optimum timing of lung resection surgery following SARS-CoV-2 infection for non-small cell lung cancer.

Yang Y, Niu L, Zhu Y, Wu Z, Xia L, Xiao C Cancer Med. 2024; 13(1):e6891.

PMID: 38169158 PMC: 10807575. DOI: 10.1002/cam4.6891.

References

Antonia S, Villegas A, Daniel D, Vicente D, Murakami S, Hui R . Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. N Engl J Med. 2017; 377(20):1919-1929. DOI: 10.1056/NEJMoa1709937. View

Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T . Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007; 25(10):1160-8. DOI: 10.1200/JCO.2005.04.7118. View

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

Detterbeck F . Achieving Clarity About Lung Cancer and Opacities. Chest. 2017; 151(2):252-254. DOI: 10.1016/j.chest.2016.08.1453. View

Zhang Y, Jheon S, Li H, Zhang H, Xie Y, Qian B . Results of low-dose computed tomography as a regular health examination among Chinese hospital employees. J Thorac Cardiovasc Surg. 2020; 160(3):824-831.e4. DOI: 10.1016/j.jtcvs.2019.10.145. View

Mao Y, Gao S, Wang Q, Shi X, Li Y, Gao W . Analysis of a registry database for esophageal cancer from high-volume centers in China. Dis Esophagus. 2019; 33(8). DOI: 10.1093/dote/doz091. View

Suzuki S, Sakurai H, Yotsukura M, Masai K, Asakura K, Nakagawa K . Clinical Features of Ground Glass Opacity-Dominant Lung Cancer Exceeding 3.0 cm in the Whole Tumor Size. Ann Thorac Surg. 2018; 105(5):1499-1506. DOI: 10.1016/j.athoracsur.2018.01.019. View

Albain K, Swann R, Rusch V, Turrisi 3rd A, Shepherd F, Smith C . Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009; 374(9687):379-86. PMC: 4407808. DOI: 10.1016/S0140-6736(09)60737-6. View

Rocco G, Nason K, Brunelli A, Varela G, Waddell T, Jones D . Management of stage IIIA (N2) non-small cell lung cancer: A transatlantic perspective. J Thorac Cardiovasc Surg. 2016; 151(5):1235-8. DOI: 10.1016/j.jtcvs.2016.01.035. View

10.

Bai Y, Yao L, Wei T, Tian F, Jin D, Chen L . Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020; 323(14):1406-1407. PMC: 7042844. DOI: 10.1001/jama.2020.2565. View

11.

Chen K . Commentary: Pay attention to low-risk populations for lung cancer, but cautiously interpret ground-glass nodules screened by low-dose computed tomography scan. J Thorac Cardiovasc Surg. 2019; 160(3):833-834. DOI: 10.1016/j.jtcvs.2019.10.204. View

12.

Allen M, Darling G, Pechet T, Mitchell J, Herndon 2nd J, Landreneau R . Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006; 81(3):1013-9. DOI: 10.1016/j.athoracsur.2005.06.066. View

13.

Peng S, Huang L, Zhao B, Zhou S, Braithwaite I, Zhang N . Clinical course of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis. J Thorac Cardiovasc Surg. 2020; 160(2):585-592.e2. PMC: 7252193. DOI: 10.1016/j.jtcvs.2020.04.005. View

14.

Travis W, Asamura H, Bankier A, Beasley M, Detterbeck F, Flieder D . The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2016; 11(8):1204-1223. DOI: 10.1016/j.jtho.2016.03.025. View

15.

Schmidt-Hansen M, Baldwin D, Hasler E, Zamora J, Abraira V, Roque I Figuls M . PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014; (11):CD009519. PMC: 6472607. DOI: 10.1002/14651858.CD009519.pub2. View

16.

Qiu J . Covert coronavirus infections could be seeding new outbreaks. Nature. 2020; . DOI: 10.1038/d41586-020-00822-x. View

17.

Chen K . Commentary: Esophageal squamous cell carcinoma: A disease requiring more research. J Thorac Cardiovasc Surg. 2020; 160(2):553-554. DOI: 10.1016/j.jtcvs.2019.11.112. View

18.

Martins R, DAmico T, Loo Jr B, Pinder-Schenck M, Borghaei H, Chaft J . The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement. J Natl Compr Canc Netw. 2012; 10(5):599-613. DOI: 10.6004/jnccn.2012.0062. View

19.

Li Y, Peng S, Li L, Wang Q, Ping W, Zhang N . Clinical and Transmission Characteristics of Covid-19 - A Retrospective Study of 25 Cases from a Single Thoracic Surgery Department. Curr Med Sci. 2020; 40(2):295-300. PMC: 7104422. DOI: 10.1007/s11596-020-2176-2. View

20.

Zhong W, Wang Q, Mao W, Xu S, Wu L, Shen Y . Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study. Lancet Oncol. 2017; 19(1):139-148. DOI: 10.1016/S1470-2045(17)30729-5. View